Generic name |
luspatercept |
---|---|
Strength |
25 mg vial and 75 mg vial |
Form |
Lyophilized powder to be reconstituted for subcutaneous injection |
Special Authority criteria |
Approval period |
---|---|
Initial coverage
|
6 months |
Renewal
|
6 months |